Skip to main content
SpringerLink
Log in

Uveitis and Clinical Trials

  • Chapter
Book cover Intraocular Inflammation

  • 212 Accesses

Abstract

Uveitis refers to approximately 25 different diseases all characterized by the presence of intraocular inflammation. The uveitides are a relatively uncommon group of diseases, with an estimated incidence in the United States of 17–54/100,000/year and prevalence of 115–204/100,000 population. Nevertheless, because uveitis affects all ages, and in many cases is a lifelong disease, it has a disproportionate effect on years of potential vision lost and is the fifth or sixth leading cause of blindness in the United States. Because it is relatively uncommon, much of the information on uveitis comes from retrospective case series rather than from prospective epidemiologic studies or randomized clinical trials. Although these case series may provide the best data available, they are subject to several limitations, which must be understood in order to interpret the information properly.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Begg C, Cho M, Eastwood S et al (1996) Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 276:637–639

    Article  CAS  PubMed  Google Scholar 

  2. Bykhovskaya I, Thorne JE, Kempen JH, Dunn JP, Jabs DA (2005) Vogt-Koyanagi-Harada disease: clinical outcomes. Am J Ophthalmol 140:674–678

    Article  PubMed  Google Scholar 

  3. Darrell RW, Wagener HP, Kurland LT (1962) Epidemiology of uveitis. Incidence and prevalence in a small urban community. Arch Ophthalmol 68:502–514

    Article  CAS  PubMed  Google Scholar 

  4. DiLoreto DA Jr, Bressler NM, Bressler SB et al (2003) Use of best and final visual acuity outcomes in ophthalmological research. Arch Ophthalmol 121:1586–1590

    Article  PubMed  Google Scholar 

  5. Foster CS, Alter G, DeBarge LR et al (1996) Efficacy and safety of rimexolone 1 % ophthalmic suspension vs 1 % prednisolone acetate in the treatment of uveitis. Am J Ophthalmol 122:171–182

    Article  CAS  PubMed  Google Scholar 

  6. Gritz DC, Wong IG (2004) Incidence and prevalence of uveitis in northern California. The Northern California Epidemiology of Uveitis Study. Ophthalmology 111:491–500

    Article  PubMed  Google Scholar 

  7. Jabs DA (1995) Ocular manifestations of HIV infection. Trans Am Ophthalmol Soc 93:623–683

    PubMed Central  CAS  PubMed  Google Scholar 

  8. Jabs DA (2005) Improving the reporting of clinical case series. Am J Ophthalmol 139:900–905

    Article  PubMed  Google Scholar 

  9. Jabs DA (2008) Epidemiology of uveitis. Ophthalmic Epidemiol 15:283–284

    Article  PubMed  Google Scholar 

  10. Jabs DA, Nussenblatt RB, Rosenbaum JT et al (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140:509–516

    Article  PubMed  Google Scholar 

  11. Kempen JH, Daniel E, Dunn JP et al (2009) Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive the-rapy: retrospective cohort study. Brit Med J 339:b2480

    Google Scholar 

  12. Kempen JH, Daniel E, Gangaputra S et al (2008) Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Ophthalmic Epidemiol 15:47–55

    Article  PubMed  Google Scholar 

  13. Kempen JH, Ganesh SK, Sangwan VS et al (2008) Interobserver agreement in grading activity and site of inflammation in eyes of patients with uveitis. Am J Ophthalmol 146:813–818

    Article  PubMed  Google Scholar 

  14. Lalezari JP, Stagg RJ, Kuppermann BD et al (1997) Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial. Ann Intern Med 126:257–263

    Article  CAS  PubMed  Google Scholar 

  15. Loteprednol Etabonate US Uveitis Study Group (1999) Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Am J Ophthalmol 127:537–544

    Article  Google Scholar 

  16. Martin DF, Kuppermann BD, Wolitz RA et al (1999) Oral ganciclovir for patients with cytomegalovirus retinitis treated with ganciclovir implant. Roche ganciclovir study group. N Engl J Med 340:1063–1070

    Article  CAS  PubMed  Google Scholar 

  17. Martin DF, Parks DJ, Mellaw SD et al (1994) Treatment of CMV retinitis with an intraocular sustained-release gancyclovir implant: A randomized controlled clinical trial. Arch Ophthalmol 112:1531–1539

    Article  CAS  PubMed  Google Scholar 

  18. Martin DF, Sierra-Madero J, for the Valganciclovir Study Group et al (2002) A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. N Engl J Med 346:1119–1126

    Google Scholar 

  19. Masuda K, Nakajima A, Urayama A et al (1989) Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet’s disease. Lancet 1:1093–1096

    Article  CAS  PubMed  Google Scholar 

  20. McCannel CA, Holland GN, Helm CJ et al (1996) Causes of uveitis in the general practice of ophthalmology. Am J Ophthalmol 121:35–46

    Article  CAS  PubMed  Google Scholar 

  21. Meinert CL (1986) Clinical trials: design, conduct, and analysis. Oxford University Press, New York

    Book  Google Scholar 

  22. Multicenter Uveitis Steroid Treatment Trial (MUST) (2008) Protocol Version 3.3. Multicenter Uveitis Steroid Treatment Trial (MUST). http://www.musttrial.org/. Accessed 11 Dec 2008

  23. Murphy CC, Greiner K, Plskova J et al (2005) Cyclosporine vs tacrolimus therapy for posterior and intermediate uveitis. Arch Ophthalmol 123:634–641

    Article  CAS  PubMed  Google Scholar 

  24. Musch DC, Martin DF, for The Ganciclovir Implant Study Group et al (1997) Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. N Engl J Med 337:83–90

    Google Scholar 

  25. Nussenblatt RB (1990) The natural history of uveitis. Int Ophthalmol 14:303–308

    Article  CAS  PubMed  Google Scholar 

  26. Nussenblatt RB, Palestine AG, Chan CC et al (1991) Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endo-genous uveitis. Am J Ophthalmol 112:138–146

    Google Scholar 

  27. Nussenblatt RB, Palestine AG, Chan CC, Roberge F (1985) Standardization of Vitreal Inflammatory Activity in Intermediate and Posterior Uveitis. Ophthalmology 92:467

    Article  CAS  PubMed  Google Scholar 

  28. Palestine AG, Polis MA, De Smet MD et al (1991) A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med 115:665–673

    Article  CAS  PubMed  Google Scholar 

  29. Rosenbaum JT, Holland GH (1996) Uveitis and the Tower of Babel. Arch Ophthalmol 114:604–605

    Article  CAS  PubMed  Google Scholar 

  30. Schachat AP, Chambers WA, Liesegang TJ et al (2003) Safe and effective. Ophthalmology 110:2073–2074

    Article  PubMed  Google Scholar 

  31. Silveira C, Belfort R Jr, Muccioli C et al (2002) The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol 134:41–46

    Article  CAS  PubMed  Google Scholar 

  32. Spector SA, Weingeist T, Pollard RB et al (1993) A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group. J Infect Dis 168:557–563

    Article  CAS  PubMed  Google Scholar 

  33. STROBE Initiative (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 147:573–577

    Article  Google Scholar 

  34. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trial Group (1996) Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS: the Cytomegalovirus Retreatment Trial. Arch Ophthalmol 114:23–33

    Article  Google Scholar 

  35. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trial Group (1997) Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. A rando-mized, controlled trial. Ann Intern Med 126:264–274

    Google Scholar 

  36. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group (1992) Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 326:213–220

    Article  Google Scholar 

  37. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group (1994) Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Ophthalmology 101:1250–1261

    Article  Google Scholar 

  38. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group (1997) MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: the Monoclonal Antibody Cytomegalovirus Retinitis Trials Group. Arch Ophthalmol 115:1528–1536

    Article  Google Scholar 

  39. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group (2001) The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial. Am J Ophthalmol 131:457–467

    Article  Google Scholar 

  40. Teoh SC, Hogan AC, Dick AD et al (2008) Mycophenolate mofetil for the treatment of uveitis. Am J Ophthalmol 146:752–760

    Article  CAS  PubMed  Google Scholar 

  41. Thorne JE, Jabs DA, Kedhar SR et al (2008) Loss of visual field among patients with birdshot chorioretinopathy. Am J Ophthalmol 145:23–28

    Article  PubMed  Google Scholar 

  42. Thorne JE, Jabs DA, Peters GB et al (2005) Birdshot retinochoroidopathy: Ocular complications and visual impairment. Am J Ophthalmol 140:45–51

    Article  PubMed  Google Scholar 

  43. Thorne JE, Jabs DA, Qazi FA et al (2005) Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology 112:1472–1477

    Article  PubMed  Google Scholar 

  44. Thorne JE, Wittenberg S, Jabs DA et al (2006) Multifocal choroiditis with panuveitis – Incidence of ocular complications and loss of visual acuity. Ophthalmology 113:2310–2316

    Article  PubMed  Google Scholar 

  45. Yazici H, Pazarli H, Barnes CG et al (1990) A controlled trial of azathioprine in Behçet’s syndrome. N Engl J Med 322:281–285

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Mount Sinai School of Medicine, Mount Sinai Hospital, 1183, New York, NY, 10029, USA

    Douglas A. Jabs MD, MBA

  2. Department of Medicine, Mount Sinai School of Medicine, Mount Sinai Hospital, New York, NY, USA

    Douglas A. Jabs MD, MBA

Authors
  1. Douglas A. Jabs MD, MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Douglas A. Jabs MD, MBA .

Editor information

Editors and Affiliations

  1. Centre of Ophthalmology, University of Tuebingen, Tuebingen, Germany

    Manfred Zierhut

  2. Biomedical Research Centre, Institute of Ophthalmology, Moorfields Eyes Hospital, Department of Medical Retina, UCL, London, United Kingdom

    Carlos Pavesio

  3. School of Medicine, Department of Ophthalmology, Hokkaido University Graduate, Sapporo, Hokkaido, Japan

    Shigeaki Ohno

  4. University of Belo Horizonte, Belo Horizonte, Brazil

    Fernando Orefice

  5. USC Eye Institute, University of Southern California, Los Angeles, California, USA

    Narsing A. Rao

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Jabs, D.A. (2016). Uveitis and Clinical Trials. In: Zierhut, M., Pavesio, C., Ohno, S., Orefice, F., Rao, N. (eds) Intraocular Inflammation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-75387-2_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-75387-2_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-75385-8

  • Online ISBN: 978-3-540-75387-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation